Analysis of clinical pharmacists' interventions in a rehabilitation setting.

IF 3.3 Q1 HEALTH POLICY & SERVICES
Journal of Pharmaceutical Policy and Practice Pub Date : 2025-04-25 eCollection Date: 2025-01-01 DOI:10.1080/20523211.2025.2450593
Lina Naseralallah, Zahra Noureddine, Afif Ahmed, Moza Al Hail, Somaya Koraysh
{"title":"Analysis of clinical pharmacists' interventions in a rehabilitation setting.","authors":"Lina Naseralallah, Zahra Noureddine, Afif Ahmed, Moza Al Hail, Somaya Koraysh","doi":"10.1080/20523211.2025.2450593","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To elucidate the role of clinical pharmacists in rehabilitation programmes by examining the type, severity, medications involved, and the level of acceptance of pharmacists' interventions.</p><p><strong>Methods: </strong>A cross-sectional study was conducted at the Qatar Rehabilitation Institute (QRI) in Doha, Qatar. Clinical pharmacists' interventions and their underlying rationales were categorised by the type of intervention using a validated classification system. The severity of these interventions was assessed using the National Patient Safety Agency (NPSA) Risk Matrix. Linear regression and chi-square analyses were employed to examine the relationships between patient-related and medication-related characteristics and the pharmacist interventions.</p><p><strong>Results: </strong>A total of 3,807 clinical pharmacists' interventions involving 815 patients were collected and analysed. The majority of patients (<i>n</i> = 501, 61.5%) had three or more interventions. Findings indicated that most interventions were addressing pharmacological strategy (<i>n</i> = 1670, 43.9%) and drug quantity (<i>n</i> = 1166, 30.7%). The most frequently reported intervention subtypes included dose optimisation (<i>n</i> = 749, 19.7%), additional drug therapy (<i>n</i> = 673, 17.7%), and medication discontinuation (<i>n</i> = 476, 12.5%). Cardiovascular agents were involved in 37.1% of the interventions, followed by endocrine medications (17.1%) and centrally acting agents (11.7%). A significant proportion of interventions were deemed to have moderate severity (79.8%). Statistical analysis revealed a positive linear correlation between age and the number of interventions per patient (<i>p</i> < 0.001); with no significant difference in the severity of interventions between adult and elderly patients (<i>p</i> = 0.09).</p><p><strong>Conclusion: </strong>This study highlights the diverse roles of clinical pharmacists in the rehabilitation field. The unique complexity of rehabilitation patients creates a challenging environment for clinical pharmacists, requiring adherence to fundamental practice principles while customising approaches to address individual patient needs. Further research is needed to assess the impact of these interventions on clinically significant outcomes.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"18 1","pages":"2450593"},"PeriodicalIF":3.3000,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12035954/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Policy and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20523211.2025.2450593","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: To elucidate the role of clinical pharmacists in rehabilitation programmes by examining the type, severity, medications involved, and the level of acceptance of pharmacists' interventions.

Methods: A cross-sectional study was conducted at the Qatar Rehabilitation Institute (QRI) in Doha, Qatar. Clinical pharmacists' interventions and their underlying rationales were categorised by the type of intervention using a validated classification system. The severity of these interventions was assessed using the National Patient Safety Agency (NPSA) Risk Matrix. Linear regression and chi-square analyses were employed to examine the relationships between patient-related and medication-related characteristics and the pharmacist interventions.

Results: A total of 3,807 clinical pharmacists' interventions involving 815 patients were collected and analysed. The majority of patients (n = 501, 61.5%) had three or more interventions. Findings indicated that most interventions were addressing pharmacological strategy (n = 1670, 43.9%) and drug quantity (n = 1166, 30.7%). The most frequently reported intervention subtypes included dose optimisation (n = 749, 19.7%), additional drug therapy (n = 673, 17.7%), and medication discontinuation (n = 476, 12.5%). Cardiovascular agents were involved in 37.1% of the interventions, followed by endocrine medications (17.1%) and centrally acting agents (11.7%). A significant proportion of interventions were deemed to have moderate severity (79.8%). Statistical analysis revealed a positive linear correlation between age and the number of interventions per patient (p < 0.001); with no significant difference in the severity of interventions between adult and elderly patients (p = 0.09).

Conclusion: This study highlights the diverse roles of clinical pharmacists in the rehabilitation field. The unique complexity of rehabilitation patients creates a challenging environment for clinical pharmacists, requiring adherence to fundamental practice principles while customising approaches to address individual patient needs. Further research is needed to assess the impact of these interventions on clinically significant outcomes.

临床药师对某康复机构的干预分析。
背景:通过检查临床药师干预的类型、严重程度、涉及的药物和接受程度来阐明临床药师在康复计划中的作用。方法:横断面研究在卡塔尔多哈的卡塔尔康复研究所(QRI)进行。临床药师的干预措施和他们的基本原理分类干预的类型使用一个有效的分类系统。使用国家患者安全局(NPSA)风险矩阵评估这些干预措施的严重程度。采用线性回归和卡方分析检验患者相关特征和药物相关特征与药师干预的关系。结果:共收集分析临床药师干预措施3807份,涉及患者815例。大多数患者(n = 501, 61.5%)接受了三种或三种以上的干预。结果显示,大多数干预措施涉及药物策略(n = 1670, 43.9%)和药物数量(n = 1166, 30.7%)。最常报道的干预亚型包括剂量优化(n = 749, 19.7%)、额外药物治疗(n = 673,17.7%)和停药(n = 476,12.5%)。37.1%的干预措施涉及心血管药物,其次是内分泌药物(17.1%)和中枢作用药物(11.7%)。相当大比例的干预措施被认为具有中度严重程度(79.8%)。统计分析显示年龄与每位患者的干预次数呈正线性相关(p p = 0.09)。结论:本研究突出了临床药师在康复领域的多元化作用。康复患者独特的复杂性为临床药师创造了一个具有挑战性的环境,要求他们遵守基本的实践原则,同时定制方法来解决个别患者的需求。需要进一步的研究来评估这些干预措施对临床显著结果的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice Health Professions-Pharmacy
CiteScore
4.70
自引率
9.50%
发文量
81
审稿时长
14 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信